Longitudinal Change of Postoperative Serum Anti-thyroglobulin Antibody Levels in Patients Without Total Thyroidectomy and Remnant Ablation

Background: There is little information regarding postoperative thyroglobulin antibody (TgAb) changes in patients without a total thyroidectomy and ablation. This study aimed to analyze the longitudinal change of TgAb levels in patients with remnant thyroid.Methods: The study group were patients who had undergone a non-total thyroidectomy for a thyroid tumor from 1996 to 2018. The median follow-up period was 3.5 years (1–7.5 years). Eligible patients had a combined serum Tg and TgAb measurement at least three times biannually. We excluded patients with thyroid dysfunction at the initial diagnosis or with papillary carcinoma who had persistent or any recurrence of disease. Results: A total of 222 patients were enrolled. In the preoperative analysis, 42 (30%) patients had positive TgAb values, and 98 were negative (70%). Seventeen years after the operation, a TgAb value over 1000 IU/ml was not seen. The positive TgAb ratio was stable for 12 years (20%–30%); however, its positivity gradually increased from 13 years onward to 53.8%. The number of patients with consistently negative and positive TgAb values was 151 (68.0%) and 48 (21.6%), respectively. The number of patients with a mixture of positive and negative TgAb values was 10 (4.5%). The number of patients who changed from positive to negative values was six (2.7%) and, inversely, seven (3.2%). Conclusions: We found positivity of TgAb after surgery gradually increases over about 10 years in patients with normal remnant thyroid. We should measure both serum Tg and TgAb values concurrently for the patients with remnant thyroid tissue throughout.

[1]  Y. Mu,et al.  Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study , 2020, Frontiers in Endocrinology.

[2]  I. Shimon,et al.  Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies. , 2020, The Journal of clinical endocrinology and metabolism.

[3]  Tae Yong Kim,et al.  Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. , 2018, Thyroid : official journal of the American Thyroid Association.

[4]  P. Trimboli,et al.  Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.

[5]  J. Jonklaas,et al.  Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. , 2014, Thyroid : official journal of the American Thyroid Association.

[6]  G. Beckett,et al.  Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference , 2013, Annals of clinical biochemistry.

[7]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[8]  T. Montesano,et al.  Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? , 2012, The Journal of clinical endocrinology and metabolism.

[9]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[10]  A. Bockisch,et al.  Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. , 2005, European journal of endocrinology.

[11]  C. Spencer Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  E. Vignali,et al.  Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens , 2003, Annals of Internal Medicine.

[13]  J. Kurebayashi,et al.  Changes of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptor , 2000, Journal of surgical oncology.

[14]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .